Adalimumab

Adamumab is a self injectable biological therapy drug that has been approved by the State Food and Drug Administration (CFDA) for two indications, namely rheumatoid arthritis and ankylosing spondylitis.

Loading...

Description

Specifications:

English name
Adalimumab
Commonly used name
Adamtuzumab Shumeile (Adamtuzumab)
English alias
Adalimumab D2E7 Humira Immunoglobulin G1, anti – (human tumor necrosis factor) (human monoclone D2E7 heavy chain), disable with human monoclone D2E7 light chain, dimer
Molecular formula
C6428H9912N1694O1987S46
Molecular weight
144190.3
Subfraction
148,108 ±8Da
Supplement
Mannitol 、 Citrate monohydratel 、 Sodium citratel 、 Sodium dihydrogen phosphate l 、dihydratel 、 Disodium hydrogen phosphate dihydratel 、 Sodium chloridel 、 Polysorbate 80l 、 Sodium hydroxidel 、 Water for injection
Subscribe to

Our Newsletter!